Trial Profile
PCIRN Evaluation of Pandemic H1N12009 Influenza Vaccine in Adults With Human Immunodeficiency Virus Infection.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 26 Aug 2023
Price :
$35
*
At a glance
- Drugs Influenza A virus vaccine-H1N1 (Primary) ; AS03A
- Indications Influenza A virus H1N1 subtype
- Focus Adverse reactions; Pharmacodynamics
- 19 May 2016 Results of substudy assessing hemagglutination inhibition and microbead array assays published in the Vaccine.
- 01 Jan 2012 Results published in the HIV Clinical Trials.
- 07 Jun 2011 Additional lead trial centre identified as reported by ClinicalTrials.gov.